NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Incyte Corp (NQ: INCY)
73.66 USD  -0.30 (-0.41%)
Official Closing Price  /  Updated: 5:23 PM EDT, Apr 22, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,242,969
Open 73.96
Bid (Size) 73.56 (1)
Ask (Size) 75.71 (2)
Prev. Close 73.96
Today's Range 72.36 - 74.64
52wk Range 57.00 - 88.83
Shares Outstanding 211,969,163
Dividend Yield N/A
Performance
YTD
+15.89%
+15.89%
1 Month
-14.02%
-14.02%
3 Month
-6.37%
-6.37%
6 Month
+14.31%
+14.31%
1 Year
+5.12%
+5.12%
Top News
More News
Merus Announces Financial Results for the Full Year 2018 and Provides Business Update
Multiple Updates from Biclonics® Clinical Trials Expected in 2019 Read More
from GlobeNewswire News Releases
BriaCell Announces Clinical Trial Collaboration Agreement with Incyte
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today... Read More
from GlobeNewswire News Releases
More News
Read More
Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019
from GlobeNewswire News Releases
Incyte to Report First Quarter Financial Results
from Business Wire News Releases
Innovent Announces 2018 Annual Results
from PR Newswire
Horton Takes Over #308 Spot From Incyte
category Stocks
from Market News Video
iOnctura Bolsters Management Team With Senior Appointments
from PR Newswire
Health-care drama has now spread to biopharma stocks
category PFE , Financial Services , MRK , and 18 more.
from MarketWatch
UPDATE 2-J&J wins U.S. FDA approval for bladder cancer drug
category companyNews
from Reuters: Company News
UPDATE 1-U.S. FDA approves J&J's bladder cancer drug
category companyNews
from Reuters: Company News
Maxim Integrated Products Becomes #18 Most Shorted Nasdaq 100 Component, Replacing Incyte
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.